Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Tretinoin alone is more effective than combined with microdermabrasion for long-term alopecia areata treatment.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

The treatment improved hair growth in three patients with alopecia.

Hair follicles can be used to study gene mutations in Stargardt disease.

Gene expression in hair follicles can help diagnose methamphetamine use disorder.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Hidradenitis suppurativa severely impacts quality of life, especially with severe symptoms and certain comorbidities, and current treatments don't significantly improve it.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Pharmacist-led care significantly improved post-COVID symptoms.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.